THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
TRUSTEES’ ANNUAL REPORT AND FINANCIAL STATEMENTS
YEAR ENDED 31 DECEMBER 2024
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
I N D E X
Year ended 31 December 2024
| Page | |
|---|---|
| General information | 2 |
| Trustees’ annual report | 3 |
| Auditors’ report | 7 |
| Statement of financial activities | 10 |
| Balance sheet | 11 |
| Notes to the financial statements | 12 |
| Appendices (These do not form part of the statutory financial statements) | |
| Investment summary | Appendix 1 |
| History of grants paid to the Royal College of Surgeons of England | Appendix 2 |
1
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
G E N E R A L I N F O R M A T I O N
Year ended 31 December 2024
| Charity Registration number | 252951 |
|---|---|
| Patron | HRH The Duke of Kent KG |
| Trustees | Justinian Ash |
| Julian Soper | |
| Jolyon Berry | |
| Antony Narula FRCS(Eng) | |
| Paul Copsey | |
| Howard Sabin FRCS(Eng), FRCS(Ed) | |
| Jonathan Randall | |
| Registered office | 22 Chancery Lane |
| London | |
| WC2A 1LS | |
| Auditors | Dixon Wilson Audit Services LLP |
| 22 Chancery Lane | |
| London | |
| WC2A 1LS | |
| Secretary | Michael Messent (Resigned 08/05/2024) |
| Stephen Finch (Appointed 08/05/2024) | |
| Principal address | Black Barn |
| Hastings Road | |
| Winchelsea | |
| East Sussex | |
| TN36 4AD | |
| Investment managers and advisers | Cazenove Capital Management Limited |
| 1 London Wall Place | |
| London | |
| EC2Y 5AU | |
| Bankers | Coutts & Co |
| St Martin’s Office | |
| 440 Strand | |
| London | |
| WC2R 0QS |
2
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
T R U S T E E S ’ A N N U A L R E P O R T
Year ended 31 December 2024
This report should be read in conjunction with the information given on page 2.
Creation
The Fund was created in 1967 as a charitable foundation by contributions from Freemasons of the English Constitution to commemorate the 250th Anniversary of the original Grand Lodge Meeting.
Governing instrument
The governing instrument is a Declaration of Trust dated 8 May 1967.
Objects and public benefit
The Trustees have considered the guidance in respect of public benefit given by the Charity Commission in accordance with the requirements of the Charities Act 2011.
The object of the Fund as set out in paragraph 5 of the Declaration of Trust, as amended by resolution of the Trustees dated 20 May 2014, is to hold the Trust Fund and the income thereof upon trust firstly to pay therefrom all the proper costs and expenses incurred by the Trustees in administering the Charity and the property thereof and subject thereto to apply the same (whether by payments from capital or income) in furthering, in conjunction with the Royal College of Surgeons of England (a registered charity no. 212808), research in the science of surgery provided that in no accounting year shall the expenditure of the Trustees towards the Royal College exceed five per centum of the capital value of the Trust Fund calculated at the end of the accounting year immediately prior to incurring such expenditure. Trust capital is held in perpetuity, subject only to the deduction of all proper costs and expenses incurred by the Trustees should these not be covered by income.
All grants are made to the Royal College of Surgeons of England in accordance with the object of the Trust. The recipient charity has confirmed that, in their opinion, its activities satisfy the public benefit test. The Trustees are satisfied that this is for the public benefit and that there is no detriment or harm that might arise from carrying out this object. No person or body receives any private benefit other than as a beneficiary.
Organisational structure
The Secretary has overall control of the general conduct of the Fund's activities and is responsible for the implementation of the policies of the Trustees.
Trustees’ policies
The Trustees' policies are:
(a) to invest trust capital in order to provide a total return to further the trust objective.
- (b) to give grants to the Royal College of Surgeons of England.
Trustees
The names of the individuals who served as Trustees during the period are shown on page 2.
The power to appoint new Trustees is vested in the Grand Master of the United Grand Lodge of England. There must be at least three and no more than seven Trustees.
The Trustees have unrestricted power of investment.
The Trustees meet at least twice each year to consider the Charity's activities and performance.
3
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
T R U S T E E S ’ A N N U A L R E P O R T
Year ended 31 December 2024
Reserves
In line with the guidance issued by the Charity Commission, the Trustees have reviewed the need for reserves. The Trustees seek to apply all income in pursuance of the stated objects of the Fund as soon as is reasonably prudent. The present intention of the Trustees is to make annual grants to the Royal College of Surgeons of England sufficient to contribute to the support of four research fellowships. The Trustees and the College seek to fund a consistent number of research fellowships, year on year, and, to achieve this objective, the Trustees may have to resort to capital, within the permitted limit. The extent to which capital has been expended over the years is reflected in the figures of net current assets as set out in note 13 on page 15.
The Trustees monitor the level of reserves regularly.
Connected charities
There are no connected charities.
Investment policy
It is the policy of the Trustees to invest widely and to be diversified by asset class, by fund manager and by security. Asset classes can include cash, bonds, equities, property, hedge funds, structured products, private equity, commodities and any other asset class that is deemed suitable for the Fund.
From September 2023 and currently the benchmark ranges for asset allocation are Global Equities 55-80%, fixed interest 5-25%, alternative investments 5-25%, and cash 0-10%. Investment in private equity assets is limited to 10% of the portfolio value. The investment policy was also updated in the year in light of market developments and it is to maintain the real value of the Fund after grants and expenses. The aim of the Trustees is to obtain an annual total return from investments sufficient to allow the disbursement of a grant to the College of £280,000 or thereabouts after covering expenses.
The Trustees seek to produce the best possible financial return in order to achieve the greatest amount of money available for the furtherance of medical research, whilst investing in a manner consistent with the Fund’s aims and avoiding investing in businesses which may reasonably be regarded as undertaking activities which are injurious to individuals or society in general. The Trustees have resolved to invest in ESG funds with a weighting of 5-10%, providing they meet all other investment criteria. It is recognised that it is unrealistic to have zero tolerance to holdings in securities due to the way some investments are held within funds and because businesses are reclassified from time to time. As shown in the following table, some tolerance of restricted businesses shall be permitted, however there shall be no direct investment in certain businesses, as specified:
| Direct investment | Total exposure overall |
|
|---|---|---|
| Tobacco | No | 1% |
| Gambling | No | 1% |
| Pornography | No | 1% |
| Predatory Lending | No | 1% |
| Fossil Fuels | Yes | 5% |
The Trustees have also resolved to invest in private assets to a limited extent in order to diversify asset classes.
The Trustees have appointed Cazenove Capital Management Limited ("Cazenove") as investment advisers. Cazenove have discretion to change the investments without the specific instructions of the Trustees. Some funds are placed on deposit with Cazenove, otherwise investments are to be held in pooled funds. Cazenove report four times a year to the Trustees on the investment performance of the Fund and the investment policy is reviewed by the Trustees at least twice a year.
4
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
T R U S T E E S ’ A N N U A L R E P O R T
Year ended 31 December 2024
Financial review
During the year investment income totalled £191,765 (2023 - £155,805). 2024 included a donation of £10,750 (2023 - £6,600), received from individual donors. All donations were treated as additions to the endowment (capital) fund with the aim of increasing the value of annual grants to the Royal College of Surgeons of England.
Grants amounting to £280,000 (2023 - £260,000) were made by the Trustees to the Royal College of Surgeons of England.
At the year-end the investments, excluding cash, were valued at £7,510,344 (2023 - £7,072,039). All investments are held in accordance with the Declaration of Trust.
The unrestricted fund shows a total deficit of £291,004 (2023 – £267,527). The Trustees have a realistic expectation that future income will be received to cover the deficit. A transfer of £291,004 from the restricted fund will be made to clear this deficit, as stated in note 13 of the accounts.
Cazenove levied investment management charges in the year amounting to £26,167 (2023 - £24,615).
In accordance with the terms of an Order granted by the Charity Commissioners dated 20 May 2011, the Trustees have identified the unapplied total return at 31 December 2012 based on the difference between the net funds at that date less the initial capital of £582,769. Additions to the unapplied total return have been calculated for subsequent accounting periods based on the excess total return less grants and expenses, as set out in note 13 to the financial statements. An application of the unapplied total return has been made in the year to 31 December 2024, in respect of the shortfall of income of £267,527 arising for the year ended 31 December 2023. The Trustees concluded that it was not necessary to obtain advice regarding the use of power conferred on the Trustees by the Order.
Financial statements
The financial statements are set out on pages 10 to 16. They have been drawn up in compliance with the relevant provisions of the Charities Act 2011 and with the Declaration of Trust.
Statement of Trustees’ responsibilities
The Trustees are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and United Kingdom Generally Accepted Accounting Practice.
Law applicable to charities in England and Wales requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the Charity's financial activities during the year and of its financial position at the end of the year. In preparing financial statements giving a true and fair view, the Trustees should follow best practice and:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles of the Charities SORP;
-
make judgments and estimates that are reasonable and prudent;
-
state whether applicable accounting standards and statements of recommended practice have been followed, subject to any material departures disclosed and explained in the financial statements; and
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in operation.
5
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
T R U S T E E S ’ A N N U A L R E P O R T
Year ended 31 December 2024
The Trustees are responsible for keeping accounting records which disclose with reasonable accuracy the financial position of the charity and which enable them to ensure that the financial statements comply with the regulations made under the Charities Act 2011. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
On behalf of the Trustees
JUSTINIAN ASH
4 September 2025
6
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
A U D I T O R S ’ R E P O R T
Year ended 31 December 2024
INDEPENDENT AUDITORS’ REPORT TO THE TRUSTEES OF THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
Opinion
We have audited the financial statements of The Freemasons’ Fund For Surgical Research (the ‘charity’) for the year ended 31 December 2024 which comprise the statement of financial activities, balance sheet, and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion, the financial statements:
-
give a true and fair view of the state of the charity’s affairs as at 31 December 2024 and of its incoming resources and application of resources for the year then ended;
-
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-
have been prepared in accordance with the requirements of the Charities Act 2011.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the trustee's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.
Other information
The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
7
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
A U D I T O R S ’ R E P O R T
Year ended 31 December 2024
Matters on which we are required to report by exception
We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 require us to report to you if, in our opinion:
-
the information given in the financial statements is inconsistent in any material respect with the trustees report; or
-
sufficient accounting records have not been kept; or
-
the financial statements are not in agreement with the accounting records; or
-
we have not received all the information and explanations we require for our audit.
Responsibilities of trustees
As explained more fully in the trustees’ responsibilities statement set out on page 5, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the trustees are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charity or to cease operations, or have no realistic alternative but to do so.
Auditor’s responsibilities for the audit of the financial statements
We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
We gained an understanding of the legal and regulatory framework applicable to the charity by considering, amongst other things, the sector in which it operates, and considered the risk of acts by the charity that were contrary to applicable laws and regulations, including fraud. We designed audit procedures to respond to the assessed level of risk, but recognised that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.
We focused on laws and regulations which could give rise to a material misstatement in the financial statements, including, but not limited to UK Charity Law and UK financial reporting standards application for UK charitable trusts.
Our tests included agreeing the financial statement disclosures to underlying supporting documentation, enquiries with management and enquiries of the investment advisors.
As in all our audits, we also addressed the risk of management override of internal controls, including testing journals and evaluating whether there was evidence of bias by management that represented a risk of material misstatement due to fraud.
8
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
A U D I T O R S ’ R E P O R T
Year ended 31 December 2024
There are inherent limitations in the audit procedures described above and, the further removed noncompliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. We did not identify any key audit matters relating to irregularities, including fraud.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.
Use of our report
This report is made solely to the charity’s trustees, as a body, in accordance with regulations made under section 154 of the Charities Act 2011. Our audit work has been undertaken so that we might state to the charity’s trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.
……………………………………… Dixon Wilson Audit Services LLP, Statutory Auditor 22 Chancery Lane London WC2A 1LS
5 September 2025
Dixon Wilson Audit Services LLP is eligible to act as an auditor in terms of section 1212 of the Companies Act 2006.
9
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
S T A T E M E N T O F F I N A N C I A L A C T I V I T I E S
Year ended 31 December 2024
| Unrestricted Endowment 2024 Unrestricted Endowment Note Funds Funds Total Funds Funds £ £ £ £ £ Income and expenditure Income and endowments from: Donations and legacies 4 - 10,750 10,750 - 6,600 Investments - 191,765 191,765 - 155,805 Total - 202,515 202,515 - 162,405 Expenditure on: Raising funds 5 - 25,845 25,845 - 25,872 Charitable activities 6 291,004 - 291,004 267,527 - Total resources expended 291,004 25,845 316,849 267,527 25,872 Net (outgoing)/incoming resources before other recognised gains and losses (291,004) 176,670 (114,334) (267,527) 136,533 Other recognised (losses)/gains: Net investment gain/(losses) in year 9 - 534,890 534,890 - 320,143 Net movement in funds for the year (291,004) 711,560 420,556 (267,527) 456,676 Transfer between funds 13 267,527 (267,527) - 267,904 (267,904) Total (deficit)/funds brought forward (267,527) 7,316,305 7,048,778 (267,904) 7,127,533 Total (deficit)/funds carried forward (page 11) (291,004) 7,760,338 7,469,334 (267,527) 7,316,305 |
2023 Total £ 6,600 155,805 162,405 25,872 267,527 293,399 (130,994) 320,143 189,149 - 6,859,629 7,048,778 |
|---|---|
All amounts are in respect of continuing operations.
10
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
B A L A N C E S H E E T
At 31 December 2024
| Note Fixed assets Investments at market value 9 Current assets Debtors 10 Cash Creditors: amounts falling due within one year 11 Net current liabilities Total net assets 13 Represented by: Capital funds – Endowment 13 Income funds – Unrestricted |
2024 2023 £ £ 7,587,456 7,169,974 13,285 3,168 32,453 153,640 45,738 156,808 (163,860) (278,004) (118,122) (121,196) 7,469,334 7,048,778 7,760,338 7,316,305 (291,004) (267,527) 7,469,334 7,048,778 |
|---|---|
The financial statements on pages 10 to 16 were approved by the Trustees on 4 September 2025.
JUSTINIAN ASH Trustee
11
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
Year ended 31 December 2024
1. General information
The Charity is an unincorporated trust. The principal address of the Charity is 7 Hansard Place, Romsey, Hampshire SO51 0EL.
2. Accounting policies
Basis of accounting
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective October 2019) – (Charities SORP (FRS 102)).
The Freemasons’ Fund for Surgical Research meets the definition of a public benefit entity under FRS 102.
Preparation of the accounts on a going concern basis
The Trustees consider that there are no material uncertainties about the Charity’s ability to continue as a going concern.
These financial statements have been prepared under the historical cost convention modified to include the revaluation of investments.
The financial statements are presented in Sterling which is the functional currency of the company and rounded to the nearest £.
Income recognition
All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received, and the amount of income receivable can be measured reliably.
Donations are recognised once the Charity has entitlement to the donations, it is certain that the donations will be received, and the monetary value of the donations can be measured with sufficient reliability.
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the bank. Dividends are recognised once the dividend has been declared and notification has been received of the dividend due.
Expenditure recognition
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the Charity to that expenditure, it is probable that settlement will be required, and the amount of the obligation can be measured reliably. For grants payable, this is the point at which the recipient is notified. All expenditure is accounted for on an accruals basis.
Investments
Investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing quoted market price. The statement of financial activities includes the net gains and losses arising on revaluation and disposals throughout the year.
Cash balances held as part of a fixed asset investment portfolio are presented as part of fixed assets.
(continued)
12
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
Year ended 31 December 2024
2. Accounting policies (continued)
Realised gains and losses
All gains and losses are taken to the Statement of Financial Activities as they arise. Realised gains and losses on investments are calculated as the difference between sales proceeds and their opening carrying value or their purchase value if acquired subsequent to the first day of the financial year. Unrealised gains and losses are calculated as the difference between the fair value at the year-end and their carrying value. Realised and unrealised investment gains and losses are combined in the Statement of Financial Activities.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities, or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
3. Staff numbers
The average number of persons employed by the charity during the year was 0 (2023 - 0).
| 4. | Voluntary income | 2024 | 2023 |
|---|---|---|---|
| £ | £ | ||
| Other | donations | 10,750 | 6,600 |
The trustees have a reasonable expectation of receiving £11,000 of voluntary income in the year ended 31 December 2025.
| 5. Expenditure on raising funds Investment management charges (Profit)/loss on foreign exchange movements |
2024 £ 26,167 (322) 25,845 |
2023 £ 24,615 1,257 |
|---|---|---|
| 25,872 |
13
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
Year ended 31 December 2024
| 6. Expenditure on charitable activities Note Grants to Royal College of Surgeons of England Governance costs: Accountancy and audit 7 Bank charges LEI provider fee |
2024 £ 280,000 10,455 489 60 291,004 |
2023 £ 260,000 7,200 244 83 |
|---|---|---|
| 267,527 | ||
| 7. Total resources expended has been stated after charging Accountancy Audit |
2024 £ 4,623 5,832 10,455 |
2023 £ 3,000 4,200 |
| 7,200 |
8. Trustees
Trustees are not remunerated, and no expenses have been reimbursed.
| 9. Investments 2024 2023 £ £ Quoted investments: Carrying value (fair value) at beginning of year 7,072,039 6,776,613 Less: proceeds of disposals (2,269,166) (1,975,933) Add: cost of additions 2,172,581 1,951,216 Net gain/(loss) for the year 534,890 320,143 Carrying value (fair value) at end of year 7,510,344 7,072,039 Cash 77,112 97,935 Total fixed asset investments 7,587,456 7,169,974 Quoted investments at cost 6,195,203 5,989,051 10. Debtors 2024 2023 £ £ Accrued income 13,285 3,168 |
9. Investments 2024 2023 £ £ Quoted investments: Carrying value (fair value) at beginning of year 7,072,039 6,776,613 Less: proceeds of disposals (2,269,166) (1,975,933) Add: cost of additions 2,172,581 1,951,216 Net gain/(loss) for the year 534,890 320,143 Carrying value (fair value) at end of year 7,510,344 7,072,039 Cash 77,112 97,935 Total fixed asset investments 7,587,456 7,169,974 Quoted investments at cost 6,195,203 5,989,051 10. Debtors 2024 2023 £ £ Accrued income 13,285 3,168 |
|---|---|
| 10. Debtors Accrued income |
2024 £ 13,285 |
14
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
Year ended 31 December 2024
11. Creditors: amounts falling due within one year
| Grants payable Accruals Other creditors |
2024 £ 150,000 13,860 - 163,860 |
2023 £ 260,000 10,804 7,200 278,004 |
|---|---|---|
12. Financial assets and liabilities
The following are financial assets that qualify as basic financial instruments and are initially recognised at their transaction value and subsequently measured at their fair value through income and expenditure:
| Financial assets Investments excluding cash |
2024 £ 7,510,344 |
2023 £ 7,072,039 |
|---|---|---|
| 13. Analysis of net assets between funds Net current Fixed assets/ assets (liabilities) Total £ £ £ Unapplied total return 4,454,682 172,882 4,627,564 Capital funds -Endowment 3,132,774 - 3,132,774 Total Endowment funds 7,587,456 172,882 7,760,338 Unrestricted funds - (291,004) (291,004) Total at 31 December 2024 7,587,456 (118,122) 7,469,334 |
At 31 December 2012, the Trustees identified that the Trust had funds of £2,742,349 representing unapplied total return, calculated as the total net assets of £3,325,118 at that date, less the initial capital of £582,769. Since that date, the following movements have taken place:
| Since that date, the following movements have taken place: | ||
|---|---|---|
| 2024 | 2023 | |
| £ | £ | |
| At 1 January | 4,194,281 | 4,012,109 |
| Investment return: dividends and interest | 191,765 | 155,805 |
| Investment return: realised and unrealised gains/(losses) | 534,890 | 320,143 |
| Investment management fees | (25,846) | (25,872) |
| Allocated to trust for application (page 10) | (267,527) |
(267,904) |
| At 31 December | 4,627,564 |
4,194,281 |
After the year-end the Trustees resolved to make a transfer of £291,004 from Endowment funds to Unrestricted funds as permitted under the constitution of the Fund.
15
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
Year ended 31 December 2024
14. Capital funds – Endowment
Endowment funds which at 31 December 2024 amounted to £7,760,338 arise from contributions received as follows from the Supreme Grand Chapter:
| follows from the Supreme Grand Chapter: | |
|---|---|
| Prior to 31 December 1969 | £582,769 |
| During the year ended 31 December 2014 | £2,424,900 |
| During the year ended 31 December 2016 | £35,000 |
| During the year ended 31 December 2017 | £22,000 |
| During the year ended 31 December 2018 | £27,733 |
| Further gifts to the endowment have been received as follows from other individuals: | |
| During the year ended 31 December 2019 | £150 |
| During the year ended 31 December 2020 | £312 |
| During the year ended 31 December 2021 | £4,935 |
| During the year ended 31 December 2022 | £14,225 |
| During the year ended 31 December 2023 | £6,600 |
| During the year ended 31 December 2024 | £10,750 |
In light of the capital contribution from the Supreme Grand Chapter in May 2014 and the value of the Fund immediately prior to its receipt, it was resolved by the Trustees that future Freemasons’ Fellowships, tenable at The Royal College of Surgeons, shall henceforth be attributed to the United Grand Lodge of England and to the Supreme Grand Chapter in the proportion of 3:2 with effect from 1 January 2015. Of the five Fellowships funded in the year ended 31 December 2024, three were attributed to the United Grand Lodge of England. The position since 1 January 2015 is as follows:
| Year | Proportion | United Grand Lodge | Supreme Grand Chapter | Total |
|---|---|---|---|---|
| 2015 | 2:2 | 2 | 2 | 4 |
| 2016 | 3:1 | 3 | 1 | 4 |
| 2017 | 3:2 | 3 | 2 | 5 |
| 2018 | 2:2 | 2 | 2 | 4 |
| 2019 | 2:2 | 2 | 2 | 4 |
| 2020 | 2:2 | 2 | 2 | 4 |
| 2021 | 2:2 | 2 | 2 | 4 |
| 2022 | 3:2 | 3 | 2 | 5 |
| 2023 | 3:2 | 3 | 2 | 5 |
| 2024 | 3:2 | 3 | 2 | 5 |
15. Related party transactions
There have been no related party transactions in the year.
16
THE FREEMASONS' FUND FOR SURGICAL RESEARCH
Appendix 1
I N V E S T M E N T S U M M A R Y
Year ended 31 December 2024
| At 1 January 2024 T |
otal additions | Disposals | At 31 D | ecember 2024 | |||
|---|---|---|---|---|---|---|---|
| 24 Absolute Return Credit Fund Altlas GIobal Infrastructure Fund Amundi Prime Wld ETF BlackRock Euro Dynamic BrevanHoward Abs Cazenove Charity Equity Value CC Private Assets Charities Property Fund Fedt Hermes Unc Credit Fidelity Global Dividend Findlay Park American Fund Fisher US SMID CoEqty FRN UK Gilt @ 1.25% FRN UK Gilt @ 4.25% 7.9.39 FRN UK Treasury 0.125% UK Treasury Hamilton Lane Impact Fund Hollyport Secoundary Opportunities HSBC Global Funds ICAV iShares Physical gold JPMorgan GBP M+G Global Dividend M+G Japan Fund ManGLG GBP Corporate bond fund Morgan Stanley GI ABS Neuberger Berman Investment Funds Ninety One Global Environment Robeco BP GIobal Premium Equity Schroder Asia Alpha Plus Fund Schroder C Semi-L Global Schroder Capital Global Private Schroder GI Sustainable Growth 5 GBP Schroder SSF Alt Assets Schroder WM Global Sustainable SPDR S+P 500 ETF The Equity Income Trust for Charities - Class S Vanguard Emerging Markets Index Fund Vanguard FTSE All-world Vanguard S+P 500 Wellington Global Health Care William Blair US Small Mid Cap WisdomTree Energy Transaction WisdomTree Gold ETC SUTL Cazenove Charity Responsible Total Capital cash |
No. - 850 - - 817 320,000 - 200,000 162,037 407,519 4,300 - 40,000 160,000 - 37,491 100,000 17,000 3,400 3,152 103,501 150,000 274,027 5,626 24,179 114,674 2,369 230,000 - 1,669 1,000,000 2,650 - - 680,745 898 1,120 3,300 20,000 977 4,000 - 909,728 |
Cost Market value No. £ £ - - 1,400 97,176 118,498 - - - 9,504 - - 47,504 81,758 89,730 - 214,305 220,096 - - - 11,450 255,388 237,200 - 156,525 141,345 - 316,752 436,045 - 193,602 672,950 - - - 1,320 81,496 82,121 - 163,162 165,072 50,000 - - 40,000 29,676 29,167 33,335 32,674 41,875 - 156,303 159,317 - 94,046 107,304 - 3,152 3,152 - 76,293 135,907 - 189,965 198,330 100,000 240,481 260,600 - 140,837 131,377 - 262,857 240,823 - 190,758 179,453 - 194,478 272,373 - 302,531 250,470 - - - 95,000 223,380 246,083 490 522,370 624,000 - 275,586 249,789 - - - 6,525 - - 880 218,589 349,426 - 110,458 107,588 - 93,564 104,895 - 219,808 234,890 - 137,837 199,988 - 88,524 105,730 - 68,522 56,920 - - - 8,700 556,198 619,525 - |
Cost No. £ 137,718 - - - 79,792 - 139,322 - - 817 - 120,000 9,337 - - 19,298 - 162,037 - 257,519 - - 170,452 - - 40,000 48,181 15,000 60,038 - 26,533 - 23,323 - - - - 3,400 - 3,152 - - 142,161 - - 14,027 344 - - 24,179 - 114,674 - 169 - - 75,007 95,000 74,266 - - 1,000,000 - 150 680,329 183 356,168 - - 230,745 (150) - 18 350 - - - - - - - - 115,036 - 34,706 21,527 |
Cost Proceeds gain/(loss) on historic cost Gain/(loss) on market value as at 31 December 2024 No. £ £ £ £ - - - 952 1,400 - - - (6,933) 850 - - - 7,311 9,504 - - - (6,081) 47,504 81,758 94,019 12,261 4,289 - 80,364 83,109 2,745 11,513 200,000 - - - 1,082 11,450 24,642 22,500 (2,142) 788 180,702 156,525 138,039 (18,486) (3,306) - 200,162 279,528 79,366 20,933 150,000 - - - 87,634 4,300 - - - (11,049) 1,320 81,496 82,414 918 293 - 15,296 15,025 (271) (15,669) 195,000 - - - 165 40,000 - - - 2,982 70,826 - - - 21,959 100,000 - - - (1,098) 17,000 94,046 127,679 33,633 20,375 - 3,152 3,152 - - - - - - 23,505 103,501 - - - 22,184 250,000 12,310 13,650 1,340 18,770 260,000 - - - (63) 5,626 262,857 242,999 (19,858) 2,176 - 190,758 186,001 (4,757) 6,548 - 13,864 21,043 7,179 21,712 2,200 - - - 24,840 230,000 75,007 74,675 (332) (332) - - - - 30,735 2,159 522,370 681,200 158,830 57,200 - 15,599 13,083 (2,516) (20,356) 2,500 19,089 20,000 911 20,857 6,342 - - - 59,887 880 74,093 118,810 44,717 10,404 450,000 - - - 7,561 898 29,244 37,240 7,996 17,288 770 - - - 60,906 3,300 - - - (1,402) 20,000 - - - 13,907 977 - - - 2,720 4,000 - - - 2,642 8,700 13,397 15,000 1,603 17,061 888,201 |
Cost £ 137,718 97,176 79,792 139,322 - 133,941 9,337 230,746 - 116,590 193,602 170,452 - 196,047 60,038 56,209 55,997 156,303 - - 76,293 332,126 228,171 141,181 - - 180,614 302,531 - 297,646 - 259,987 661,240 356,168 144,496 110,308 64,338 219,808 137,837 88,524 68,522 115,036 577,507 |
Market value £ 138,670 111,565 87,103 133,241 - 148,500 10,419 215,488 - 177,450 760,584 159,403 - 182,559 60,203 58,682 87,157 158,219 - - 159,412 362,675 265,720 131,658 - - 273,042 275,310 - 351,084 - 216,350 681,186 416,055 241,020 114,999 84,961 295,796 198,586 119,637 59,640 117,678 656,292 7,510,344 77,112 7,587,456 |
Unrealised gain/(loss) £ 952 14,389 7,311 (6,081) - 14,559 1,082 (15,258) - 60,860 566,982 (11,049) - (13,488) 165 2,473 31,160 1,916 - - 83,119 30,549 37,549 (9,523) - - 92,428 (27,221) - 53,438 - (43,637) 19,946 59,887 96,524 4,691 20,623 75,988 60,749 31,113 (8,882) 2,642 78,785 |
| 4,986,029 | 5,989,051 7,072,039 406,107 |
2,172,581 2,122,227 |
1,966,029 2,269,166 303,137 534,890 3,269,910 |
6,195,603 | 1,314,741 | ||
| 97,935 97,935 6,086,986 7,169,974 |
2,172,581 | 1,966,029 2,269,166 303,137 534,890 |
77,112 | ||||
| 6,272,715 | 1,314,741 |
This page does not form part of the statutory financial statements 17
THE FREEMASONS’ FUND FOR SURGICAL RESEARCH
Appendix 2
H I S T O R Y O F G R A N T S P A I D T O T H E R O Y A L C O L L E G E O F S U R G E O N S O F E N G L A N D
Grants have been made to The Royal College of Surgeons of England as follows:
| Year | £ |
|---|---|
| 1968 | 12,000 |
| 1969 | 25,500 |
| 1970 | 35,000 |
| 1971 | 30,000 |
| 1972 | 30,300 |
| 1973 | 30,000 |
| 1974 | 30,000 |
| 1975 | 30,000 |
| 1976 | 30,000 |
| 1977 | 59,100 |
| 1978 | 45,060 |
| 1979 | 40,000 |
| 1980 | 45,000 |
| 1981 | 60,000 |
| 1982 | 50,000 |
| 1983 | 55,000 |
| 1984 | 115,000 |
| 1985 | 86,125 |
| 1986 | 72,875 |
| 1987 | 75,000 |
| 1988 | 97,500 |
| 1989 | 95,000 |
| 1990 | 105,000 |
| 1991 | 105,000 |
| 1992 | 110,648 |
| 1993 | 115,000 |
| 1994 | 120,000 |
| 1995 | 136,000 |
| 1996 | 140,000 |
| 1997 | 145,000 |
| 1998 | 147,500 |
| 1999 | 155,000 |
| 2000 | 145,000 |
| 2001 | 140,000 |
| 2002 | 120,000 |
| 2003 | 120,000 |
| 2004 | 126,000 |
| 2005 | 155,700 |
| 2006 | 135,000 |
| 2007 | 145,500 |
| 2008 | 145,500 |
| 2009 | 135,000 |
| 2010 | 135,000 |
| 2011 | 130,000 |
| 2012 | 135,000 |
| 2013 | 135,000 |
| 2014 | 135,000 |
| 2015 | 220,000 |
| 2016 | 220,000 |
| 2017 | 250,000 |
| 2018 | 220,000 |
| 2019 | 220,000 |
| 2020 | 180,000 |
| 2021 | 260,000 |
| 2022 | 260,000 |
| 2023 | 260,000 |
| 2024 | 280,000 |
| 6,835,308 |
This page does not form part of the statutory financial statements
18